JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells

Cell

Volumn 119, Issue 3, 2004, Pages 431-443

  Passegué, Emmanuelle ^a   Wagner, Erwin F ^b   Weissman, Irving L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL TEST; FREQUENCY ANALYSIS; GENE; GENE ACTIVATION; GENE INACTIVATION; GENE OVEREXPRESSION; HEMATOPOIETIC CELL; JUNB GENE; LEUKEMIA; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOUSE; MYELOPOIESIS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STEM CELL;

ANIMALIA;

EID: 7044269527     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2004.10.010     Document Type: Article

References (46)

1. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that give rise to all myeloid lineages. Nature. 404:1999;193-197
2. Allsopp R.C., Weissman I.L. Replicative senescence of hematopoietic stem cells during serial transplantation. does telomere shortening play a role? Oncogene. 21:2002;3270-3273
3. Antonchuk J., Sauvageau G., Humphries R.K. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell. 109:2002;39-45
4. Bhardwaj G., Murdoch B., Wu D., Baker D.P., Williams K.P., Chadwick K., Ling L.E., Karanu F.N., Bhatia M. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat. Immunol. 2:2001;172-180
5. Bose S., Deininger M., Gora-Tybor J., Goldman J.M., Melo J.V. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals. biologic significance and implication for the assessment of minimal residual disease Blood. 92:1998;3362-3367
6. Bruchova H., Borovanova T., Klamova H., Brdicka R. Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea. Leuk. Lymphoma. 43:2002;1289-1295
7. Christensen J.L., Weissman I.L. Flk-2 is a marker in hematopoietic stem cell differentiation. a simple method to isolate long-term stem cells Proc. Natl. Acad. Sci. USA. 98:2001;14541-14546
8. Clarkson B., Stife A., Wisniewski D., Lambek C.L., Liu C. Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies. Leukemia. 17:2003;1211-1262
9. Cozzio A., Passegué E., Ayton P.M., Karsunky H., Cleary M.L., Weissman I.L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17:2003;3029-3035
10. Domen J. The role of apoptosis in regulating hematopoiesis and hematopoietic stem cells. Immunol. Res. 22:2000;83-94
11. Domen J., Gandy K.L., Weissman I.L. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood. 91:1998;2272-2282
12. Dorsam S.T., Ferrell C.M., Dorsam G.P., Derynck M.K., Vijapurkar U., Khodabakhsh D., Pau B., Bernstein H., Haqq C.M., Largman C., Lawrence H.J. The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells. Blood. 103:2003;1676-1684
13. + cells in patients with chronic myeloid leukemia treated with imatinib mesylate. Exp. Hematol. 31:2003;702-707
14. Fialkow P.J., Jacobson R.J., Papayannopoulou T. Chronic myelocytic leukemia. clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage Am. J. Med. 63:1977;125-130
15. Fialkow P.J., Martin P.J., Najfed V. Evidence of a multi-step pathogenesis of chronic myelogenous leukemia. Blood. 58:1981;158-163
16. Jamieson C.H., Ailles L.E., Dylla S.J., Muijtjens M., Jones C., Zehnder J.L., Gotlib J., Li K., Manz M.G., Keating A., Sawyers C.L., Weissman I.L. Granulocyte/Macrophage progenitors in chronic myelogenous leukemia are candidate leukemic stem cells that activate the beta-catenin pathway. N. Engl. J. Med. 351:2004;657-667
17. Jaiswal S., Traver D., Miyamoto T., Akashi K., Lagasse E., Weissman I.L. Development of murine chronic and acute myelogenous leukemia with targeted expression of BCR/ABL to myeloid progenitors. Proc. Natl. Acad. Sci. USA. 100:2003;10002-10007
18. Kantarjian H.M., O'Brien S., Cortes J., Giles F.J., Faderl S., Issa J.P., Garcia-Manero G., Rios M.B., Shan J., Andreeff M., Keating M., Talpaz M. Results of decitabine (5-aza-2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia. Cancer. 98:2003;522-528
19. Kenner L., Hoebertz A., Beil T., Keon N., Karreth F., Eferl R., Scheuch H., Szremska A., Amling M., Schorpp-Kistner M., Angel P., Wagner E.F. Mice lacking JunB are osteopenic due to cell autonomous osteoblast and osteoclast defects. J. Cell Biol. 164:2004;613-623
20. Kogan S.C., Ward J.M., Anver M.R., Berman J.J., Brayton C., Cardiff R.D., Carter J.S., de Coronado S., Downing J.R., Fredrickson T.N. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood. 100:2002;238-245
21. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 91:1997;661-672
22. Kühn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science. 269:1995;1427-1429
23. Lagasse E., Weissman I.L. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med. 179:1994;1047-1052
24. Lessard J., Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 423:2003;255-260
25. Li S., Ilaria R.L. Jr., Million R.P., Daley G.Q., Van Etten R.A. The p190, p220, and p230 forms of the Bcr-Abl oncogene induce a similar chronic myeloid leukemia-like symdrome in mice but have different lymphoid leukemogenic activity. J. Exp. Med. 189:1999;1399-1412
26. Matioli G.T. BCR-ABL insufficiency for the transformation of human stem cells into CML. Med. Hypotheses. 59:2002;588-589
27. Miyamoto T., Weissman I.L., Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl. Acad. Sci. USA. 97:2000;7521-7526
28. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., Morrison S.J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 425:2003;962-967
29. Morrison S.J., Wright D.E., Weissman I.L. Identification of a lineage of multipotent hematopoietic progenitors. Development. 124:1997;1929-1939
30. Na Nakorn T., Traver D., Weissman I.L., Akashi K. Myeloerythroid- restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J. Clin. Invest. 199:2002;1579-1585
31. Orkin S.H. Diversification of hematopoietic stem cells to specific lineages. Nat. Rev. Genet. 1:2000;57-64
32. Park I.-K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 423:2003;302-305
33. Passegué E., Wagner F. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J. 19:2000;2969-2979
34. Passegué E., Jochum W., Schorpp-Kistner M., Möhle-Steinlein U., Wagner E.F. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking JunB expression in the myeloid lineage. Cell. 104:2001;21-32
35. Passegué E., Jamieson C.H.E., Ailles L.E., Weissman I.L. Normal and leukemic hematopoiesis. are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc. Natl. Acad. Sci. USA. 100(Suppl. 1):2003;11842-11849
36. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature. 414:2001;105-111
37. Reya T., Duncan A., Ailles L., Domen J., Scherer D., Willert K., Hintz L., Nusse R., Weissman I.L. Regulation of hematopoietic stem cell self renewal by the Wnt signaling pathway. Nature. 423:2003;409-414
38. Sawyers C.L. Chronic myeloid leukemia. N. Engl. J. Med. 340:1999;1330-1340
39. Schorpp-Kistner M., Wang Z.-Q., Angel P., Wagner E.F. JunB is essential for mammalian placentation. EMBO J. 18:1999;934-948
40. Spangrude G.J., Heimfeld S., Weissman I.L. Purification and characterization of mouse hematopoietic stem cells. Science. 241:1988;58-62
41. Tallquist M.D., Soriano P. Epiblast-restricted Cre expression in MORE mice. a tool to distinguish embryonic vs. extra-embryonic gene function Genesis. 26:2000;113-115
42. Tenen D.G. Disruption of differentiation in human cancer. AML shows the way Nat. Rev. Cancer. 3:2003;89-101
43. Thorsteinsdottir U., Mamo A., Kroon E., Jerome L., Bijl J., Lawrence H.J., Humphries K., Sauvageau G. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell. Blood. 99:2002;121-129
44. Traver D., Akashi K., Weissman I.L., Lagasse E. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity. 9:1998;47-57
45. Varnum-Finney B., Xu L., Brashem-Stein C., Nourigat C., Flowers D., Bakkour S., Pear W.S., Bernstein I.D. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat. Med. 6:2000;1278-1281
46. Yang M.Y., Liu T.C., Chang J.G., Lin P.M., Lin S.F. JunB gene expression is inactivated by methylation in chronic myeloid leukemia. Blood. 101:2003;3205-3211